TEMOGET 20MG

Temoget 20mg Capsule contains temozolomide as its active ingredient and is classified as an antitumor agent. It is used to treat brain tumors, including glioblastoma multiforme in adults and malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma in patients over three years of age. Glioblastoma and anaplastic astrocytoma are aggressive forms of brain cancer with poor survival rates. Anaplastic astrocytoma is managed with Temoget 20mg Capsule or radiotherapy following a biopsy, whereas glioblastoma multiforme is treated with a combination of radiotherapy and Temoget 20mg Capsule, which is continued as maintenance therapy.

Many patients also inquire about the price of Temoget 20mg before commencing treatment. It is crucial to understand how Temoget 20mg functions: it disrupts the DNA of cancer cells, inhibiting their growth and replication, thereby aiding in the control of tumor progression. This medication is primarily utilized as Temoget 20mg for the treatment of brain tumors during both the initial and maintenance phases.